ReviewInternational journal of molecular sciences2022
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.
Hyein Jo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it